Exome Asset Management »

STAAR Surgical Company shares owned by Exome Asset Management

Quarter-by-quarter ownership of STAAR Surgical Company (STAA) shares owned by Exome Asset Management from 13F filings

Historical chart of Exome Asset Management investment in STAAR Surgical Company

Tip: Access up to 7 years of quarterly data

All positions including STAAR Surgical Company held by Exome Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in STAAR Surgical Company by Exome Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.5M 41k 37.15

More positions owned by Exome Asset Management

Eli Lilly & Co. (LLY)
Ascendis Pharma A/s Sponsored Adr (ASND)
Bridgebio Pharma (BBIO)
Structure Therapeutics Sponsored Ads (GPCR)
Tg Therapeutics (TGTX)
Align Technology (ALGN)
Cigna Corp (CI)
Gilead Sciences (GILD)
Geron Corporation (GERN)
Biontech Se Sponsored Ads (BNTX)
Bristol Myers Squibb (BMY)
Miragen Therapeutics (VRDN)
Intuitive Surgical Com New (ISRG)
Beigene Sponsored Adr
Blueprint Medicines (BPMC)

View all positions for Exome Asset Management

Top funds holding STAAR Surgical Company

Broadwood Capital
BlackRock
Vanguard Group
State Street Corporation
Geode Capital Management
Baillie Gifford & Co
Resona Asset Management
Armistice Capital
Dimensional Fund Advisors
Luke P. La Valle, Jr.
Morgan Stanley
Yunqi Capital
Millennium Management
Defender Capital
Geneva Capital Management

View all funds holding STAAR Surgical Company